| DNA lentivector for transduction information: |
GENTAUR suggests to use our ABM packaging mix LV003 of second generation virusses or the LV053, This DNA can alos be used for packaging into Lentiviral particles for high efficiency transduction and stably integrated expressions, Vectors with selection markers like kanamycin, our 3rd Generation Packaging mixture, pLenti lentiviral plasmids DNAs are stored in 10milliMolar Tris/HCI with 1mM EDTA at a pH of 8 at -25 C, puromycin or cumate are available, Lentiveral packaging plasmid DNA for non-viral plasmid transfection and direct use in plasmid expression |
| Properties: |
Depending on the epitopes used human ELISA kits can be cross reactive to many other species, Mainly analyzed are human serum, Modern , cDNA and human recombinants are used in human reactive ELISA kits and to produce anti-human mono and polyclonal antibodies, human cell culture supernatants and biological samples, plasma, primarily , saliva, urine, , (Homo sapiens, Homo sapiens sapiens), Human proteins, humans , ssp |
| Gene target: |
CHRNA7 Lentiviral Vector (CMV) (pLenti-GIII-CMV-C-term-HA) |
| Short name: |
CHRNA7 Lentiviral Vector ( ) (CMV) (pLenti-GIII-CMV-C-term-HA) |
| Technique: |
Vectors |
| Species: |
Humans, Human |
| Alternative name: |
a 7 (neuronal) Lentiviral integrating Desoxyribonucleic acid sequence (H, nicotinic, sapiens) (cytomegalovirus) (pLenti-GIII-cytomegalovirus-c terminus-HA), cholinergic receptor |
| Alternative to gene target: |
CHRNA7 and IDBG-5070 and ENSG00000175344 and 1139, CHRNA7 and IDBG-630821 and ENSBTAG00000015775 and 282178, CHRNA7-2 and NACHRA7, Cell surfaces, Chrna7 and IDBG-190675 and ENSMUSG00000030525 and 11441, alpha 7 (neuronal), nicotinic, protein homodimerization activity, this GO :0000187 and activation of MAPK activity and biological process this GO :0001540 and beta-amyloid binding and molecular function this GO :0001666 and response to hypoxia and biological process this GO :0004889 and acetylcholine-activated cation-selective channel activity and molecular function this GO :0005230 and extracellular ligand-gated ion channel activity and molecular function this GO :0005886 and plasma membrane and cellular component this GO :0005892 and acetylcholine-gated channel complex and cellular component this GO :0006810 and transport and biological process this GO :0006811 and ion transport and biological process this GO :0006816 and calcium ion transport and biological process this GO :0006874 and cellular calcium ion homeostasis and biological process this GO :0007165 and signal transduction and biological process this GO :0007268 and synaptic transmission and biological process this GO :0007613 and memory and biological process this GO :0008284 and positive regulation of cell proliferation and biological process this GO :0015464 and acetylcholine receptor activity and molecular function this GO :0015643 and toxic substance binding and molecular function this GO :0016020 and membrane and cellular component this GO :0016021 and integral component of membrane and cellular component this GO :0017081 and chloride channel regulator activity and molecular function this GO :0022848 and acetylcholine-gated cation channel activity and molecular function this GO :0030054 and cell junction and cellular component this GO :0032720 and negative regulation of tumor necrosis factor production and biological process this GO :0034220 and ion transmembrane transport and biological process this GO :0035094 and response to nicotine and biological process this GO :0042166 and acetylcholine binding and molecular function this GO :0042803 and protein homodimerization activity and molecular function this GO :0045211 and postsynaptic membrane and cellular component this GO :0045766 and positive regulation of angiogenesis and biological process this GO :0050890 and cognition and biological process, this GO :0001540 : beta-amyloid binding, this GO :0001540 : beta-amyloid binding and also this GO :0004889 : acetylcholine-activated cation-selective channel activity and also this GO :0005230 : extracellular ligand-gated ion channel activity and also this GO :0015464 : acetylcholine receptor activity and also this GO :0015643 : toxic substance binding and also this GO :0017081 : chloride channel regulator activity and also this GO :0022848 : acetylcholine-gated cation channel activity and also this GO :0042166 : acetylcholine binding and also this GO :0042803 : protein homodimerization activity, this GO :0004889 : acetylcholine-activated cation-selective channel activity, this GO :0005230 : extracellular ligand-gated ion channel activity, this GO :0015464 : acetylcholine receptor activity, this GO :0015643 : toxic substance binding, this GO :0017081 : chloride channel regulator activity, this GO :0022848 : acetylcholine-gated cation channel activity, this GO :0042166 : acetylcholine binding, this GO :0042803 : protein homodimerization activity, 89832, cholinergic receptor |
| Identity: |
1960 |
| Gene: |
CHRNA7 |
More about : CHRNA7 |
| Long gene name: |
cholinergic receptor nicotinic alpha 7 subunit |
| Synonyms gene name: |
alpha 7 (neuronal) cholinergic receptor, alpha polypeptide 7 cholinergic receptor, cholinergic receptor, nicotinic, nicotinic, nicotinic alpha 7 |
| Synonyms name: |
acetylcholine receptor, alpha 7 (neuronal) , nicotinic |
| Locus: |
15q13, 3 |
| Discovery year: |
1993-05-25 |
| GenBank acession: |
Z23141 |
| Entrez gene record: |
1139 |
| Pubmed identfication: |
8188270 |
| Classification: |
Cholinergic receptors nicotinic subunits |
| Havana BLAST/BLAT: |
OTTHUMG00000129285 |